Souhaitez-vous accéder aux communiqués récents ?

SAN FRANCISCO, April 27, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for...

Dublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Biologics Contract Research Organization Market: Industry Trends and Global Forecasts - Distribution by Type of Biologic, Scale of Operation,...

Dublin, April 16, 2026 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Global Pharmaceutical Industry, 2026" report has been added to ResearchAndMarkets.com's offering.The global pharmaceutical...

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "COVID 19 - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report provides a detailed examination of over...

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Bispecific Antibodies - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report offers comprehensive...

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "RNA Therapies - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report provides detailed insights into 80+...

Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Biopharmaceutical CMO & CRO Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The...

Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Purvalanol A (CDK Inhibitor) Market Report 2026" has been added to ResearchAndMarkets.com's offering. The Purvalanol A (CDK Inhibitor) market has...

AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly Amended agreement reflects growing excitement in the field for targeting intracellular Tau and...

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Adrenocortical Carcinoma Market Report 2026" has been added to ResearchAndMarkets.com's offering. The adrenocortical carcinoma market is on a...